Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Griffith & Werner Inc. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD)'s Breast Cancer Study Success Drives Investor Optimism Amid Broader Market Slump

Vident Advisory LLC Lowers Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Two Sigma Investments LP Sells 458,712 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead (GILD) to Acquire HOOK for $10 million

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by USS Investment Management Ltd

Gilead's ASCENT-03 Study Of Trodelvy In First-line MTNBC Meets Primary Goal

Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire

Gilead Sciences Inc. (GILD) - Insider Monkey

Vident Advisory LLC Sells 29,112 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Woodline Partners LP Sells 1,193,336 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Needham & Company LLC Reaffirms Hold Rating for Gilead Sciences (NASDAQ:GILD)

Soviero Asset Management LP Sells 3,000 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Brokerages Set Gilead Sciences, Inc. (NASDAQ:GILD) Price Target at $110.55

WBI Investments LLC Raises Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Triglav Skladi D.O.O. Acquires New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

Link Between Viral Infection and Alzheimer's Emerges in New Data

Baron Discovery Fund Initiated a Position in Arcellx (ACLX)

Zurich Insurance Group Ltd FI Has $83.96 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Unusual Options Alert: The Smart Money is Piling Into Gilead Sciences (GILD)

WBI Investments LLC Increases Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Sarissa Capital Management LP Lowers Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells $249,550.00 in Stock

Gilead Sciences discovers new PRMT5 inhibitors | BioWorld

Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Shell Asset Management Co.

Snowden Capital Advisors LLC Lowers Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Quantinno Capital Management LP Acquires 58,305 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Sen. John Boozman Sells Gilead Sciences, Inc. (NASDAQ:GILD) Stock

Mufg Securities Americas Inc. Buys New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

Man Group plc Purchases 243,567 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts

Precision Medicine Market worth $246.66 billion by 2029 with 11.1% CAGR | MarketsandMarkets™ | ABNewswire

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Increased by ProShare Advisors LLC

ProShare Advisors LLC Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Point72 Asia Singapore Pte. Ltd.

Point72 Europe London LLP Sells 34,903 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Lazard Asset Management LLC

LMR Partners LLP Purchases Shares of 56,799 Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Janus Henderson Group PLC

Focus Partners Wealth Increases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

OMERS ADMINISTRATION Corp Sells 733 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Main Street Group LTD Sells 232 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Man Group plc Boosts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Morgens Waterfall Vintiadis & Co. Inc. Acquires Shares of 40,000 Gilead Sciences, Inc. (NASDAQ:GILD)

Graham Capital Management L.P. Purchases Shares of 18,886 Gilead Sciences, Inc. (NASDAQ:GILD)

Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification

Why Gilead Sciences (GILD) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom

Gilead Sciences Investing $32B to Boost U.S. Biopharmaceutical Manufacturing

Measured Risk Portfolios Inc. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

LMR Partners LLP Makes New $5.25 Million Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Q2 EPS Estimates for Gilead Sciences Raised by Analyst
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know
US Healthcare Industry Outlook Report 2025 Featuring Market Influencers - Pfizer, Johnson & Johnson, Roche, AbbVie, Amgen, Novartis, Merck, Gilead Sciences, Sanofi, Bristol-Myers Squib, and B. Braun

Gilead Sciences, Inc. (NASDAQ:GILD) Position Trimmed by First Manhattan CO. LLC.
Is Gilead Sciences (GILD) Among the Best Stocks to Buy According to Jim Simons' Renaissance Technologies?

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Guardian Wealth Advisors LLC NC

Ensign Peak Advisors Inc Acquires 60,474 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Ethic Inc. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Cetera Investment Advisers Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Decreased by Fiduciary Trust Co

6,347 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Cary Street Partners Financial LLC

Deutsche Bank AG Sells 992,259 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by CoreCap Advisors LLC

Cresset Asset Management LLC Sells 74,671 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Ameriprise Financial Inc. Decreases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Algert Global LLC Acquires Shares of 34,791 Gilead Sciences, Inc. (NASDAQ:GILD)

Rep. Marjorie Taylor Greene Buys Gilead Sciences, Inc. (NASDAQ:GILD) Stock

Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment

Ethic Inc. Purchases 7,638 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Ensign Peak Advisors Inc Boosts Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Cornerstone Select Advisors LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Crestline Management LP Purchases 5,875 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements

NORTHAMPTON, MA / ACCESS Newswire / May 8, 2025 / Creating a

Earth Day Focus for Gilead Sciences - Every Action Has an Impact | Morningstar

Deutsche Bank AG Reduces Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Brown Advisory Inc. Has $25.61 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment

Gilead (GILD): Livdelzi Shows Promising Results for PBC Treatment | GILD Stock News

21,600 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Bayesian Capital Management LP

Benjamin Edwards Inc. Has $16.27 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Bearing Point Capital LLC Invests $588,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead's Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was ...

New HIV integrase inhibitors disclosed in Gilead patent | BioWorld

Health Care Down Due to Regulatory Fears - Health Care Roundup | Morningstar

Fighting the World's Most Devastating Diseases Is the Focus of This Installment of "The ...

Gilead (GILD) Sees Bearish Options Activity with Heavy Put Trading | GILD Stock News

BNP Paribas Sells 2,996 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Alteri Wealth LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
/Gilead%20Sciences%2C%20Inc_%20pills-by%20%20Marc%20Bruxelle%20via%20Shutterstock.jpg)
What Are Wall Street Analysts' Target Price for Gilead Sciences Stock?

Axa S.A. Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)

6,719 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Accredited Wealth Management LLC
Latest news
Show more
Morning Note: Japan's Core Inflation Spikes; UK Retail Surges; Canada Sales Slow

Morning Note: Nvidia Slams China Chip Ban; Bitcoin Climbs on Trade Peace;